International Clinical and Medical Case Reports Journal (ISSN: 2832-5788) | Volume 3, Issue 11 | Opinion Article | Open Access

Targeted Cancer Therapies: Advancing Personalized Oncology

Nemat Khansari^*

Department of Immunology, Tehran University of Medical Sciences, Iran

^*Correspondence to: Nemat Khansari 

Abstract

In the dynamic landscape of cancer treatment, the emergence of targeted cancer therapies has revolutionized the way we approach this complex and multifaceted disease. These personalized approaches target specific molecular alterations or pathways that drive tumor growth, offering the potential for more effective and less toxic treatments than traditional chemotherapy [1].

Advances in our understanding of cancer biology and the advent of sophisticated genomic technologies have paved the way for developing these targeted therapies. By mapping the unique mutations and molecular signatures within a patient's tumor, clinicians can select therapies tailored to the individual's specific cancer profile, ushering in a new era of personalized cancer medicine.

Keywords:

Citation:

Khansari N. Targeted Cancer Therapies: Advancing Personalized Oncology. Int Clinc Med Case Rep Jour. 2024;3(11):1-3.